Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2

Virus Research

Volumn 136, Issue 1-2, 2008, Pages 8-15

  Wang, Shunxin ^a   Guo, Feng ^a   Liu, Kangtai ^a   Wang, Hongliang ^a   Rao, Shuan ^a   Yang, Peng ^a   Jiang, Chengyu ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Angiotensin converting enzyme 2 (ACE2); Endocytosis; N Linked glycosylation; Receptor binding domain (RBD); Severe acute respiratory syndrome coronavirus (SARS CoV)

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; HYBRID PROTEIN; IMMUNOGLOBULIN G1; RBD FC PROTEIN; VIRUS RECEPTOR; VITRONECTIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; SARS CORONAVIRUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; ENDOCYTOSIS; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; MEMBRANE GLYCOPROTEINS; PEPTIDYL-DIPEPTIDASE A; PROTEIN BINDING; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; SARS VIRUS; VIRAL ENVELOPE PROTEINS;

SARS CORONAVIRUS;

EID: 46249132335     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2008.03.004     Document Type: Article

References (37)

1. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., and Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 61 (1990) 1303-1313
2. Babcock G.J., Esshaki D.J., Thomas Jr. W.D., and Ambrosino D.M. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J. Virol. 78 (2004) 4552-4560
3. Chakraborti S., Prabakaran P., Xiao X., and Dimitrov D.S. The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization. Virol. J. 2 (2005) 73-82
4. Drosten C., Günther S., Preiser W., van der Werf S., Brodt H., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A.M., Berger A., Burguière A., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J., Müller S., Rickerts V., Stürmer M., Vieth S., Klenk H., Osterhaus A.D.M.E., Schmitz H., and Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1967-1976
5. Fenouillet E., Gluckman J.C., and Bahraoui E. Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. J. Virol. 64 (1990) 2841-2848
6. Goffard A., Callens N., Bartosch B., Wychowski C., Cosset F.L., Montpellier C., and Dubuisson J. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J. Virol. 79 (2005) 8400-8409
7. Greber U.F. Signalling in viral entry. Cell. Mol. Life Sci. 59 (2002) 608-626
8. Haun G., Keppler O.T., Bock C.T., Herrmann M., Zentgraf H., and Pawlita M. The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus. J. Virol. 67 (1993) 7482-7492
9. He Y., Zhou Y., Liu S., Kou Z., Li W., Farzan M., and Jiang S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem. Biophys. Res. Commun. 324 (2004) 773-781
10. Hofmann H., Hattermann K., Marzi A., Gramberg T., Geier M., Krumbiegel M., Kuate S., Uberla K., Niedrig M., and Pöhlmann S. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J. Virol. 78 (2004) 6134-6142
11. Inoue, Y., Tanaka, N., Tanaka, Y., Inoue, S., Morita, K., Min, Z., Hattori, T., Sugamura, K. Clathrin-dependent entry of SARS coronavirus into target cells expressing cytoplasmic tail-deleted ACE2. J. Virol. (in press).
12. Ksiazek T.G., Erdman D., Goldsmith C., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Nghiem K.H., Dowell A., Ling S., Humphrey C., Shieh W., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J., Cox N., Hughes J., LeDuc J.W., Bellini W.J., Anderson L.J., and the SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1953-1966
13. Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A.S., Liu D., Qin C., Jiang C., and Penninger J.M. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11 (2005) 875-879
14. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophase T4. Nature 227 (1970) 680-685
15. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., Ahuja A., Yung M.Y., Leung C.B., To K.F., Lui S.F., Szeto C.C., Chung S., and Sung J.J.Y. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348 (2003) 1986-1994
16. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
17. Li F., Li W., Farzan M., and Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 (2005) 1864-1868
18. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., and Roper R.L. The genome sequence of the SARS-associated coronavirus. Science 300 (2003) 1399-1404
19. Marsh M., and Helenius A. Virus entry: open sesame. Cell 124 (2006) 729-740
20. Moore J.P., McKeating J.A., Norton W.A., and Sattentau Q.J. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4. J. Virol. 65 (1991) 1133-1140
21. Nemerow G.R. Cell receptors involved in adenovirus entry. Virology 274 (2000) 1-4
22. Ohuchi M., Ohuchi R., Feldmann A., and Klenk H.D. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J. Virol. 71 (1997) 8377-8384
23. Oldstone M.B., Lewicki H., Thomas D., Tishon A., Dales S., Patterson J., Manchester M., Homann D., Naniche D., and Holz A. Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98 (1999) 629-640
24. Pelkmans L., and Helenius A. Insider information: what viruses tell us about endocytosis. Curr. Opin. Cell Biol. 15 (2003) 414-422
25. Pelkmans L., Puntener D., and Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296 (2002) 535-539
26. Poutanen S.M., Low D.E., Henry B., Finkelstein S., Rose D., Green K., Tellier R., Draker R., Adachi D., Ayers M., Chan A.K., Skowronski D.M., Salit I., Simor A.E., Slutsky A.S., Doyle P.W., Krajden M., Petric M., Brunham R.C., and McGeer A.J. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348 (2003) 1995-2005
27. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Peñaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Günther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., and Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300 (2003) 1394-1399
28. Scearce-Levie K., Lieberman M.D., Elliott H.H., and Conklin B.R. Engineered G protein coupled receptors reveal independent regulation of internalization, desensitization and acute signaling. BMC. Biol. 3 (2005) 3
29. Simmons G., Reeves J.D., Rennekamp A.J., Amberg S.M., Piefer A.J., and Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoproteinmediated viral entry. Proc. Natl. Acad. Sci. USA 101 (2004) 4240-4245
30. Spiga O., Bernini A., Ciutti A., Chiellini S., Menciassi N., Finetti F., Causarono V., Anselmi F., Prischi F., and Niccolai N. Molecular modeling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochem. Biophys. Res. Commun. 310 (2003) 78-83
31. Sui J., Li W., Murakami A., Tamin A., Matthews L.J., SWong K., Moore M.J., Tallarico A.S., Olurinde M., Choe H., Anderson L.J., Bellini W.J., Farzan M., and Marasco W.A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. USA 101 (2004) 2536-2541
32. Tsang K.W., Ho P.L., Ooi G.C., Yee W.K., Wang T., Chan-Yeung M., Lam W.K., Seto W.H., Yam L.Y., Cheung T.M., Wong P.C., Lam B., Ip M.S., Chan J., Yuen K.Y., and Lai K.N. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348 (2003) 1977-1985
33. Wahl S.M., Allen J.B., Gartner S., Orenstein J.M., Popovic M., Chenoweth D.E., Arthur L.O., Farrar W.L., and Wahl L.M. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand recept1ors and chemotactic function of peripheral blood monocytes. J. Immunol. 142 (1989) 3553-3559
34. Wang S., Chou T.H., Sakhatskyy P.V., Huang S., Lawrence J.M., Cao H., Huang X., and Lu S. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. J. Virol. 79 (2005) 1906-1910
35. Wang H., Yang P., Liu K., Guo F., Zhang Y., Zhang G., and Jiang C. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 18 (2008) 290-301
36. Wong S.K., Li W., Moore M.J., Choe H., and Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 279 (2004) 3197-3201
37. Yang Z.Y., Huang Y., Ganesh L., Leung K., Kong W.P., Schwartz O., Subbarao K., and Nabel G.J. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC SIGN. J. Virol. 78 (2004) 5642-5650